Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy.
about
Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malariaOpsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area.Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria.Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal.Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytesHigh avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria.Designing a VAR2CSA-based vaccine to prevent placental malaria.Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoitesThe antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding siteThe impact of lipid-based nutrient supplementation on anti-malarial antibodies in pregnant women in a randomized controlled trial.Malaria and immunity during pregnancy and postpartum: a tale of two speciesCD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do soProspects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.Malaria during Pregnancy.Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study.Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian WomenA model of parity-dependent immunity to placental malaria.HIV and co-infections.A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation.Developing vaccines to prevent malaria in pregnant women.Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort.HIV-1 infection and antibodies to Plasmodium falciparum in adults.Minimal Impact by Antenatal Subpatent Plasmodium falciparum Infections on Delivery Outcomes in Malawian Women: A Cohort Study.Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens.A versatile, high through-put, bead-based phagocytosis assay for Plasmodium falciparum.Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.Clinical outcomes of submicroscopic infections and correlates of protection of VAR2CSA antibodies in a longitudinal study of pregnant women in Colombia.IgM and IgG against Plasmodium falciparum lysate as surrogates of malaria exposure and protection during pregnancy.Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon
P2860
Q30603697-C72FB673-A033-4D5F-AA47-5CE34119593CQ31169310-BA4F8293-950E-4557-9A6E-96237C7654F7Q33532592-2C1377B0-76E4-4863-BEBB-AEF1E2A38CE1Q33593182-7349CFD8-4040-453F-B8A7-8DA827C7E412Q33842019-21D60C07-BDD6-425A-894D-643361A4B7CDQ33946646-B226812F-5077-4EA0-9F3D-19E1B3B426D4Q34161839-44367DC5-1F13-4F5A-8526-4CAEF8AAE25BQ34171651-4C334EEC-A35C-4527-8F20-E5B606F4BF86Q34326742-F4A6C4AC-86D4-43EE-85F9-F93C9CC6FB16Q34498103-64078A68-826D-40B8-B0CC-2B7D99A0320BQ34534163-2C4ED86E-7AE8-48FA-AA85-412BE41019BBQ34540211-5EA1956B-0CEB-46D3-98D0-497FD9409CD0Q35088554-8D38AE97-0ACB-4545-B3A9-86D3AE728837Q35627041-1576F552-10E3-41E7-B2A2-78E92D03AE58Q35678578-5D6DD664-0909-4AC8-97C5-289C0094D6DFQ35684739-4C32ABD5-D4A8-42DC-9CCC-1F2CB0C45B98Q35738477-8DF018C8-9697-442E-A084-F25AD0C69936Q36284603-6676482A-EDE0-4C79-B9EF-6BF32EC3250AQ36336978-925BE7E3-0F76-4BA8-BC85-4925242E5B69Q36644516-EB146FA3-7274-4137-8636-A11E469A94F0Q36737343-32A03B1E-208C-4868-AB3F-750F91CAC62BQ36970184-FC0224A2-7DE4-4072-AF54-C6EA56DFB9DBQ37298050-AF050B63-2B42-49FE-999B-E5093790872DQ37396439-3936835A-E4B0-46D8-BE0E-8CB21442C433Q37406034-8B834167-DAA6-4842-86C4-E279E61630A5Q38519513-F49B9238-5A91-4268-8A1A-95FC2A2B00EAQ38882700-490A5D90-32B1-4D79-8BE1-CA67A73B0FD7Q39052051-8A6112A2-03AB-4274-A04C-D6631191C9F0Q39514602-2ADB2B9D-A2E8-4DF5-B38B-C990FF9AE8EDQ41992842-C0B8227A-38D0-45B7-8827-6F58329331E5Q46558019-72058D60-0528-4E2D-B5F2-EA3FFEC6A4E9Q48023771-00C563B7-79D3-4452-B4BF-BB66252CE0E5Q48023815-539DF9D4-8C09-41A5-96F9-DB5080B9F600Q53819699-B8C68993-4F24-4BA8-A369-3DA89F42A9EEQ56341834-1A68CF69-847A-4F17-A220-FC921A2D416D
P2860
Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibodies to variant surface ...... opment of anemia in pregnancy.
@en
Antibodies to variant surface ...... opment of anemia in pregnancy.
@nl
type
label
Antibodies to variant surface ...... opment of anemia in pregnancy.
@en
Antibodies to variant surface ...... opment of anemia in pregnancy.
@nl
prefLabel
Antibodies to variant surface ...... opment of anemia in pregnancy.
@en
Antibodies to variant surface ...... opment of anemia in pregnancy.
@nl
P2093
P2860
P50
P921
P356
P1476
Antibodies to variant surface ...... opment of anemia in pregnancy.
@en
P2093
Anthony Jaworowski
Francisca Yosaatmadja
Gaoqian Feng
Linda Kalilani
P2860
P304
P356
10.1086/599841
P407
P577
2009-07-01T00:00:00Z